Assessment of Egfr Mutation Status in Matched Plasma and Tumor Tissue of Nsclc Patients from A Phase I Study of Rociletinib (Co-1686)
Chris Karlovich,Jonathan W. Goldman,Jong-Mu Sun,Elaina Mann,Lecia V. Sequist,Krzysztof Konopa,Wei Wen,Philipp Angenendt,Leora Horn,David Spigel,Jean-Charles Soria,Benjamin Solomon,D. Ross Camidge,Shirish Gadgeel,Cloud Paweletz,Lin Wu,Sean Chien,Patrick O'Donnell,Shannon Matheny,Darrin Despain,Lindsey Rolfe,Mitch Raponi,Andrew R. Allen,Keunchil Park,Heather Wakelee CLINICAL CANCER RESEARCH（2016）
关键词
EGFR Mutations,EGFR Inhibitors
AI 理解论文
溯源树
样例
